ASH Data Bring UniQure Closer To Filing Hemophilia B Gene Therapy

Late-Breaking Data Suggest Activity At Level Needed For Approval

Nov 19 2020

• By Alaric DeArment

UniQure will present topline Phase III data at ASH • Source: Shutterstock

More from Blood and Clotting

More from Therapeutic Category